These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9121006)
21. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. Hirano T; Fujimoto J; Ueki T; Yamamoto H; Iwasaki T; Morisita R; Sawa Y; Kaneda Y; Takahashi H; Okamoto E Gene Ther; 1998 Apr; 5(4):459-64. PubMed ID: 9614569 [TBL] [Abstract][Full Text] [Related]
22. Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis. von der Thüsen JH; Fekkes ML; Passier R; van Zonneveld AJ; Mainfroid V; van Berkel TJ; Biessen EA Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):357-62. PubMed ID: 14699016 [TBL] [Abstract][Full Text] [Related]
23. Gene transfer into the glomerulus by the hemagglutinating virus of Japan-liposome method. Imai E; Isaka Y; Akagi Y; Kaneda Y Exp Nephrol; 1997; 5(2):112-7. PubMed ID: 9108992 [No Abstract] [Full Text] [Related]
24. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase. Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277 [TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy. Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695 [TBL] [Abstract][Full Text] [Related]
26. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes. Tomita N; Morishita R; Yamamoto K; Higaki J; Dzau VJ; Ogihara T; Kaneda Y J Gene Med; 2002; 4(5):527-35. PubMed ID: 12221646 [TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated arterial gene therapy for restenosis: problems and perspectives. Feldman LJ; Tahlil O; Steg PG Semin Interv Cardiol; 1996 Sep; 1(3):203-8. PubMed ID: 9552512 [TBL] [Abstract][Full Text] [Related]
28. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases. Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037 [TBL] [Abstract][Full Text] [Related]
29. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors. Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724 [TBL] [Abstract][Full Text] [Related]
30. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Hayashi K; Nakamura S; Morishita R; Moriguchi A; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Sakai N; Ogihara T Gene Ther; 2000 Oct; 7(19):1664-71. PubMed ID: 11083475 [TBL] [Abstract][Full Text] [Related]
31. Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys. Nakamura H; Morishita R; Kaneda Y In Vivo; 2002; 16(1):45-8. PubMed ID: 11980360 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy. Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002 [TBL] [Abstract][Full Text] [Related]
33. Towards gene therapy for renal diseases. Imai E; Akagi Y; Isaka Y Nephrologie; 1998; 19(7):397-402. PubMed ID: 9857374 [TBL] [Abstract][Full Text] [Related]
34. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439 [TBL] [Abstract][Full Text] [Related]
35. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives. Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585 [TBL] [Abstract][Full Text] [Related]